(Q24187732)

30 June 2019

meta-analysis

0 references

title

Topical clonidine for neuropathic pain (English)

1 reference

30 June 2019

0 references

2

Jaroslaw Woron

Jaroslaw

Woron

1 reference

30 June 2019

5

Jerzy Wordliczek

Jerzy

Wordliczek

1 reference

30 June 2019

1

Anna Wrzosek

Anna

Wrzosek

1 reference

30 June 2019

3

Jan

Dobrogowski

Jan Dobrogowski

1 reference

30 June 2019

author name string

Joanna Jakowicka-Wordliczek

series ordinal

4

author given names

Joanna

author last names

Jakowicka-Wordliczek

1 reference

30 June 2019

publication date

31 August 2015

1 reference

30 June 2019

Cochrane Database of Systematic Reviews

published in

1 reference

30 June 2019

volume

8

1 reference

30 June 2019

page(s)

CD010967

1 reference

30 June 2019

Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage 'enriched enrollment' design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Topical application of clonidine relieves hyperalgesia in patients with sympathetically maintained pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Transdermal clonidine versus placebo in painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Pain and the brain: specificity and plasticity of the brain in clinical chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Prevalence of chronic pain with neuropathic characteristics in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Pharmacological evidence for different alpha 2-adrenergic receptor sites mediating analgesia and sedation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Topical capsaicin (low concentration) for chronic neuropathic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Topical capsaicin (high concentration) for chronic neuropathic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Topical clonidine antinociception

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Epidural clonidine analgesia for intractable cancer pain. The Epidural Clonidine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

alpha(2)-adrenergic agonists for regional anesthesia. A clinical review of clonidine (1984-1995).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Peripheral analgesic effect of intra-articular clonidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Intra-articular morphine and clonidine produce comparable analgesia but the combination is not more effective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Intrathecal clonidine in the treatment of intractable pain: a phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Epidemiology and Clinical Features of Idiopathic Trigeminal Neuralgia and Glossopharyngeal Neuralgia: Similarities and Differences, Rochester, Minnesota, 1945-1984

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Alpha 2 adrenoceptor-mediated presynaptic inhibition of primary afferent glutamatergic transmission in rat substantia gelatinosa neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Topical lidocaine for the treatment of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Incidence of facial pain in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Perineural alpha(2A)-adrenoceptor activation inhibits spinal cord neuroplasticity and tactile allodynia after nerve injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Duloxetine for treating painful neuropathy or chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Brain imaging of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Size is everything--large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Pregabalin for acute and chronic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

"Evidence" in chronic pain--establishing best practice in the reporting of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Fibromyalgia: Moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Numbers-needed-to-treat analyses--do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Gabapentin for chronic neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen/paracetamol combinations after third molar extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Amitriptyline for neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Gabapentin for chronic neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Clonidine: clinical pharmacology and therapeutic use in pain management

21 January 2018

2 references

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

21 January 2018

12 December 2020

Treatment of neuropathic pain: an overview of recent guidelines

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Trigeminal neuralgia: the role of self-sustaining discharge in the trigeminal ganglion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Comparative assessment of the anaesthetic and analgesic effects of intramuscular and epidural clonidine in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Topical and peripherally acting analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

alpha-Adrenoceptor and opioid receptor modulation of clonidine-induced antinociception

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Neuropathic pain: a pathway for care developed by the British Pain Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Neuropathic features of joint pain: a community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Pregabalin in fibromyalgia--responder analysis from individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

The Epidemiology of Chronic Pain of Predominantly Neuropathic Origin. Results From a General Population Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Can neuroimaging studies identify pain endophenotypes in humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Neuropathic pain: redefinition and a grading system for clinical and research purposes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Carbamazepine for chronic neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Neuropathic pain: aetiology, symptoms, mechanisms, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Oxcarbazepine for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010967.PUB2

Topical opioids in mice: analgesia and reversal of tolerance by a topical N-methyl-D-aspartate antagonist.

21 January 2018

1 reference

12 December 2020

Clinical experience with transdermal clonidine in African-American and Hispanic-American patients with hypertension: evaluation from a 12-week prospective, open-label clinical trial in community-based clinics

1 reference

12 December 2020

Antinociception by epidural and systemic alpha(2)-adrenoceptor agonists and their binding affinity in rat spinal cord and brain.

1 reference

12 December 2020

Alpha2-adrenergic receptors in human dorsal root ganglia: predominance of alpha2b and alpha2c subtype mRNAs

1 reference

12 December 2020

Analgesic synergy between topical lidocaine and topical opioids.

1 reference

12 December 2020

Preliminary report: the efficacy of clonidine hydrochloride ointment for postherpetic neuralgia

1 reference

12 December 2020

Intrathecal Clonidine and Severe Hypotension After Cardiopulmonary Bypass

1 reference

12 December 2020

Effects of topical application of clonidine cream on pain behaviors and spinal Fos protein expression in rat models of neuropathic pain, postoperative pain, and inflammatory pain

1 reference

12 December 2020

Coexpression of alpha 2A-adrenergic and delta-opioid receptors in substance P-containing terminals in rat dorsal horn

1 reference

12 December 2020

Patient-centered perspective on treatment outcomes in chronic pain

1 reference

12 December 2020

A new definition of neuropathic pain

1 reference

12 December 2020

1 reference

12 December 2020

Neuropathic pain: treatment guidelines and updates.

1 reference

12 December 2020

Advances in topical analgesics

1 reference

12 December 2020

Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy

1 reference

12 December 2020

[Which way for the administration of alpha 2-adrenergic agents to obtain the best analgesia?]

1 reference

12 December 2020

Multiple receptors involved in peripheral alpha 2, mu, and A1 antinociception, tolerance, and withdrawal.

1 reference

12 December 2020

10.1002/14651858.CD010967.PUB2

Identifiers

DOI

1 reference

30 June 2019

release_32kwphgy7zdk7pg54bp2vxypx4

Fatcat ID

0 references

PMCID

6489438

1 reference

30 June 2019

PubMed ID

26329307

1 reference

30 June 2019